Metastatic Gastric Adenocarcinoma Recruiting Phase 3 Trials for Capecitabine (DB01101)

Also known as: Adenocarcinoma gastric / Adenocarcinoma of stomach (disorder)

DBCOND0074521 (Metastatic Gastric Adenocarcinoma)Recruiting3 IdentifierTitlePurposeDrugs
NCT04248452Testing the Addition of Radiotherapy to the Usual Treatment (Chemotherapy) for Patients With Esophageal and Gastric Cancer That Has Spread to a Limited Number of Other Places in the BodyTreatment